Join the Anthrax Prophylaxis group to help and get support from people like you.
Anthrax Prophylaxis News
FDA Approves Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted) Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
GAITHERSBURG, Md., July 20, 2023 (GLOBE NEWSWIRE) – Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cyfendus (Anthrax Vaccine...
FDA Approves Anthim (obiltoxaximab) for Inhalation Anthrax
March 21, 2016 – On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial...
FDA Approves BioThrax for Use After Known or Suspected Anthrax Exposure
November 23, 2015 – The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to...
FDA Approves Raxibacumab to Treat Inhalational Anthrax
December 14, 2012 – The U.S. Food and Drug Administration today approved raxibacumab injection to treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
amoxicillin, doxycycline, Cipro, ciprofloxacin, Levaquin, levofloxacin